Autoinjectors Market Introduction and Overview
According to SPER Market Research, the Global Autoinjectors Market is estimated to reach USD 41.82 billion by 2033 with CAGR of 16.34%.
The report includes an in-depth analysis of the South Korea Autonomous Ships Market, including market size and trends, product mix, Types, and supplier analysis. Drugs, mostly life-saving ones, are administered once by autoinjectors. With a focus on safe and secure drug administration, these spring-loaded syringe autoinjectors are used. A paradigm shift and market leadership have come from the auto-injector delivery system. Artificial intelligence has led to the replacement of insulin with more sophisticated autoinjectors, which are mostly used to administer human growth hormones. As prefilled syringes, spring-loaded syringes are often single-use, disposable autoinjectors. Easy to use and meant for patient self-administration or administration by unskilled individuals, autoinjectors are designed with ease of use in mind.
- May 2022: The Qfinity autoinjector platform was introduced by Jabil Healthcare, a part of Jabil Inc. It is an easy-to-use, reusable, and modular solution for subcutaneous (SC) drug self-administration that is less expensive than competing products on the market.
- October 2022: Biocorp and BD teamed to use Biocorp's Injay technology, which gives prefilled syringes additional connectivity. It is anticipated to help BD monitor drug adherence to injectables that are self-administered.
Market Opportunities and Challenges
Autoinjectors have several benefits, such as quicker and simpler medicine administration. Conditions such as opiate overdose and anaphylactic shocks necessitate prompt medical attention. The epinephrine autoinjectors are advantageous for individuals who have experienced anaphylactic shocks in the past because of their portability and speed of administration. As a result, autoinjectors are essential for treating illnesses that require immediate medical attention. Additionally, the players in the autoinjector market are refocusing their efforts on developing autoinjectors with technological innovations like connectivity for improved support, audio-visual cues for simple handling and administration, and large dose and volume devices for less frequent drug administration. These developments collectively encourage the use of autoinjectors in home care settings, creating opportunities in the market.
A drug's viscosity influences several aspects of its administration. Drugs can be delivered by autoinjectors at a precise volume and viscosity at a precise injection speed. The viscosity of the substance influences the autoinjector's design. For example, spring-powered autoinjectors need springs with various physical characteristics, like length, thickness, and composition that are appropriate for the drug's viscosity. For autoinjectors, then, the one-size-fits-all principle does not apply. The problem in developing an auto injector that can handle varying viscosities is to ensure safety and accuracy while supporting varying injection volumes and rates. Moreover, intricate designing for various viscosities and volumes may have an effect on the autoinjector device's functionality.
Market Competitive Landscape
Details per competitor are provided by the competitive landscape of the Global Autoinjectors industry. The firm's overview, financials, revenue, market potential, R&D investment, new market initiatives, regional presence, company strengths and weaknesses, product introduction, product width and breadth, and application domination are all mentioned in the details. Some of major players are Abbie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed and various others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Application, By Type, By End User
|
| Regions covered | North America, Europe, Asia - Pacific, Middle East, and Africa, and South America
|
| Companies Covered | Abbie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed and various others.
|
COVID-19 Impact on Global Autoinjectors Market
The number of patients postponing seeking therapy and treatment has drastically decreased after the limits were changed. Positive effects of COVID-19 have been seen in the autoinjector market. Patients now have more choice and control over their therapy thanks to the COVID-19 epidemic and increased demand for self-injections. Improved injection speed and anxiety management are made possible by the sophisticated technologies that have brought back the popularity of autoinjectors. The pharmaceutical business Catalent Biologics has observed a rise in demand for autoinjectors during the epidemic. With autoinjectors, chronic illnesses and allergies can be easily and rapidly managed without the need for hospital visits, thanks to the requirement for remote monitoring and excellent home care.
Key Target Audience:
- Pharmaceutical and Biotechnology Companies
- Medical Device Manufacturers
- Healthcare Professionals
- Patients
- Hospitals and Clinics
- Pharmacies and Drug Retailers
- Patient Advocacy Groups
- Research and Academic Institutions
- Training and Education Providers
Our in-depth analysis of the Autoinjectors Market includes the following segments:
|
By Application: |
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
|
|
By Type: |
Disposable Autoinjectors
Reusable Autoinjectors
|
|
By End User: |
Home Care Settings
Hospital and Clinics
Others
|
Key Topics Covered in the Report:
- Global Autoinjectors Market Size (FY’2023-FY’2033)
- Overview of Global Autoinjectors Market
- Segmentation of Global Autoinjectors Market By Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others)
- Segmentation of Global Autoinjectors Market By Type (Disposable Autoinjectors and Reusable Autoinjectors)
- Segmentation of Global Autoinjectors Market By End User (Home Care Settings, Hospital and Clinics, and Others)
- Statistical Snap of Global Autoinjectors Market
- Expansion Analysis of Global Autoinjectors Market
- Problems and Obstacles in Global Autoinjectors Market
- Competitive Landscape in the Global Autoinjectors Market
- Impact of COVID-19 and Demonetization on Global Autoinjectors Market
- Details on Current Investment in Global Autoinjectors Market
- Competitive Analysis of Global Autoinjectors Market
- Prominent Players in the Global Autoinjectors Market
- SWOT Analysis of Global Autoinjectors Market
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impact of the Global Autoinjectors Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Autoinjectors Market Manufacturing Base Distribution, Sales Area, Type, Application
6.2. Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Global Autoinjectors Market
7. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)
7.1. Global Autoinjectors Market Value Share and Forecast, By Application, 2024-2033
7.2. Anaphylaxis
7.3. Multiple Sclerosis
7.4. Rheumatoid Arthritis
7.5. Others
8. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)
8.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
8.2. Disposable Autoinjectors
8.3. Reusable Autoinjectors
9. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)
9.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
9.2. Home Care Settings
9.3. Hospital and Clinics
9.4. Others
10. Global Autoinjectors Market Forecast, 2020-2033 (USD Million)
10.1. Global Autoinjectors Market Size and Market Share
11. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)
11.1. Global Autoinjectors Market Size and Market Share By Application (2020-2026)
11.2. Global Autoinjectors Market Size and Market Share By Application (2027-2033)
12. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)
12.1. Global Autoinjectors Market Size and Market Share By Type (2020-2026)
12.2. Global Autoinjectors Market Size and Market Share By Type (2027-2033)
13. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)
13.1. Global Autoinjectors Market Size and Market Share By End User (2020-2026)
13.2. Global Autoinjectors Market Size and Market Share By End User (2027-2033)
14. Global Autoinjectors Market, By Region, 2020-2033 (USD Million)
14.1. Global Autoinjectors Market Size and Market Share By Region (2020-2026)
14.2. Global Autoinjectors Market Size and Market Share By Region (2027-2033)
14.2.1. Africa
14.2.2. Asia – Pacific
14.2.3. Europe
14.2.4. Middle East
14.2.5. North America
14.2.6. South America
15. Company Profile
15.1. Abbie
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Type summary
15.1.4. Recent developments
15.2. Amgen
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Type summary
15.2.4. Recent developments
15.3. Bayer
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Type summary
15.3.4. Recent developments
15.4. Becton
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Type summary
15.4.4. Recent developments
15.5. Dickinson and Company
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Type summary
15.5.4. Recent developments
15.6. Eli Lilly
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Type summary
15.6.4. Recent developments
15.7. Novartis
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Type summary
15.7.4. Recent developments
15.8. Teva Pharmaceuticals
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Type summary
15.8.4. Recent developments
15.9. Ypsomed
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Type summary
15.9.4. Recent developments
15.10. Others
15 List of Abbreviations
16 Reference Links
17 Conclusion
18 Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
